These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6147052)

  • 21. Reduction of gastric acidity with ranitidine or famotidine: early evening dosage is more effective than late evening dosage.
    Bauerfeind P; Cilluffo T; Emde C; Fimmel C; Kohler W; Gasser T; Blum AL
    Digestion; 1987; 37(4):217-22. PubMed ID: 2890546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of acid inhibition on Campylobacter pylori.
    Blanco M; Pajares JM; Jimenez ML; Lopez-Brea M
    Scand J Gastroenterol Suppl; 1988; 142():107-9. PubMed ID: 2901784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of refractory chronic Zollinger-Ellison syndrome--treated successfully with famotidine].
    Shiratori K; Watanabe S; Maruyama M; Adachi H; Itoh Y; Kurokawa K; Takeuchi T
    Nihon Shokakibyo Gakkai Zasshi; 1984 Jul; 81(7):1623-7. PubMed ID: 6149326
    [No Abstract]   [Full Text] [Related]  

  • 24. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
    Campoli-Richards DM; Clissold SP
    Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
    Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of famotidine and ranitidine in duodenal ulcer].
    Rohner HG; Gugler R; Kimmig JM; Schönekäs H
    Dtsch Med Wochenschr; 1987 Feb; 112(9):367-8. PubMed ID: 2880704
    [No Abstract]   [Full Text] [Related]  

  • 27. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
    Hamilton MI; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Famotidine (Pepcid).
    Med Lett Drugs Ther; 1987 Feb; 29(733):17-8. PubMed ID: 2880282
    [No Abstract]   [Full Text] [Related]  

  • 29. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
    Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
    J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
    Lachman L; Howden CW
    Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interest of ranitidine, a new H2 receptor antagonist in the treatment of Zollinger-Ellison syndrome (author's transl)].
    Mignon M; Vallot T; Mayeur S; Treffot MJ; Bonfils S
    Gastroenterol Clin Biol; 1981 Jan; 5(1):42-7. PubMed ID: 6110608
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study.
    Maton PN; Frucht H; Vinayek R; Wank SA; Gardner JD; Jensen RT
    Gastroenterology; 1988 Feb; 94(2):294-9. PubMed ID: 3335308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP; Grebenev AL; Kkhorshed AM
    Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of patients with gastrin-producing tumors (Zollinger-Ellison syndrome)].
    Ponomarev AA
    Vopr Onkol; 1984; 30(9):14-20. PubMed ID: 6149652
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diagnostic and therapeutic strategy of Zollinger-Ellison syndrome. Groupe de Recherches et d'Etudes du Syndrome de Zollinger-Ellison (GRESZE)].
    Bonnaud G; Cadiot G; Mignon M
    Ann Chir; 1994; 48(6):535-46. PubMed ID: 7847702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uncertainties in the management of the Zollinger-Ellison Syndrome.
    Malagelada JR
    Gastroenterology; 1983 Jan; 84(1):188-9. PubMed ID: 6128287
    [No Abstract]   [Full Text] [Related]  

  • 37. A randomized clinical trial comparing the efficacy of ranitidine and famotidine on intragastric acidity in critically ill pediatric patients.
    Aanpreung P; Vanprapar N; Susiva C; Parkpreaw C; Boonyachart C
    J Med Assoc Thai; 1998 Mar; 81(3):185-9. PubMed ID: 9623009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring.
    Vallot T; Mignon M; Mazure R; Bonfils S
    Dig Dis Sci; 1983 Jul; 28(7):577-84. PubMed ID: 6305607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Zollinger-Ellison syndrome--diagnosis and management.
    Mee AS
    S Afr Med J; 1985 Sep; 68(7):499-501. PubMed ID: 2864745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.